Thi Hong Van Le Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

1/2020

Engineered M13 Peptide Carrier Promotes Angiogenic Potential of Patient-Derived Human Cardiac Progenitor Cells and In Vivo Engraftment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thi Hong Van Le Research Topics

Disease

4	Neoplasms (Cancer) 05/2021 - 08/2015
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2018
1	Rheumatic Diseases (Rheumatism) 05/2021
1	Eye Diseases (Eye Disease) 05/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Myocardial Infarction 01/2020
1	Atherosclerosis 01/2019
1	Obesity 01/2019
1	Carcinogenesis 01/2018
1	Colitis 08/2015

Drug/Important Bio-Agent (IBA)

2	falcarinolIBA 01/2018 - 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2021
1	Peptides (Polypeptides)IBA 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 12/2019
1	PlatinumIBA 12/2019
1	Antineoplastic Agents (Antineoplastics)IBA 12/2019
1	AdiponectinIBA 01/2019
1	GinsenosidesIBA 08/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2015
1	ocotillolIBA 08/2015
1	Interleukin-17 (Interleukin 17)IBA 08/2015
1	majonoside R2IBA 08/2015
1	AcidsIBA 08/2015
1	InterleukinsIBA 08/2015

Therapy/Procedure

2	Therapeutics 05/2021 - 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2020
1	Transplantation 01/2020
1	Cell Transplantation 01/2020